Compound Global Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Compound Global Advisors's ELV Position: Q1 2026 in Review
Compound Global Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 164 shares — an estimated $57.5K sold.
Compound Global Advisors first reported a position in ELV in Q4 2024 and held it in 5 quarters. The position peaked at $1.14M in Q4 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Compound Global Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Compound Global Advisors sold 164 Elevance Health shares in Q1 2026, an estimated $57.5K.
- Compound Global Advisors first reported a position in Elevance Health in Q4 2024 and held it in 5 quarters.
- Compound Global Advisors's Elevance Health position peaked at $1.14M in Q4 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Compound Global Advisors's 13F filing for Q1 2026, filed 7 May 2026.